SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-15-009719
Filing Date
2015-12-24
Accepted
2015-12-24 13:09:05
Documents
4
Period of Report
2015-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k122115_actiniumpharma.htm 8-K 26374
2 INVESTORS RIGHTS AGREEMENT f8k122115e10i_actinium.htm EX-10.1 136613
3 PRESS RELEASE f8k122115ex99i_actinium.htm EX-99.1 15754
4 GRAPHIC ex99i_001.jpg GRAPHIC 17624
  Complete submission text file 0001213900-15-009719.txt   204425
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 151307798
SIC: 2834 Pharmaceutical Preparations